β cell responses to inflammation
Autor: | Ana Luisa Perdigoto, Sahar Usmani-Brown, Pamela Clark, Gabriel Betancur, Nathalie Lavoie, Jinxiu Rui, Kevan C. Herold, Maria Korah |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
lcsh:Internal medicine Programmed cell death Cell 030209 endocrinology & metabolism Inflammation Apoptosis Disease Review Methylation Pathogenesis 03 medical and health sciences 0302 clinical medicine Insulin-Secreting Cells medicine Animals Humans Epigenetics lcsh:RC31-1245 Molecular Biology business.industry Beta cells Cell Biology 3. Good health Death 030104 developmental biology Cell killing medicine.anatomical_structure Type 1 diabetes Diabetes Mellitus Type 1 Cancer research medicine.symptom business |
Zdroj: | Molecular Metabolism Molecular Metabolism, Vol 27, Iss, Pp S104-S113 (2019) |
ISSN: | 2212-8778 |
Popis: | Background: The extended and clinically silent progression of Type 1 diabetes (T1D) creates a challenge for clinical interventions and for understanding the mechanisms that underlie its pathogenesis. Over the course of the development of Type 1 diabetes, studies in animal models and of human tissues have identified adaptive changes in β cells that may affect their immunogenicity and susceptibility to killing. Loss of β cells has traditionally been identified by impairment in function but environmental factors may affect these measurements. Scope of Review: In this review we will highlight features of β cell responses to cell death, particularly in the setting of inflammation, and focus on methods of detecting β cell death in vivo. Major conclusions: We developed an assay to measure β cell death in vivo by detecting cell free DNA with epigenetic modifications of the INS gene that are found in β cells. This assay has robust technical performance and identifies killing in individuals at very high risk for disease, but its ability to identify β cell killing in at-risk relatives is limited by the short half-life of the cell free DNA and the need for repeated sampling over an extended course. We present results from the Diabetes Prevention Trial-1 using this assay. In addition, recent studies have identified cellular adaptations in some β cells that may avoid killing but impair metabolic function. Cells with these characteristics may aggravate the autoimmune response but also may represent a potentially recoverable source of functional β cells. Keywords: Beta cells, Apoptosis, Death, Type 1 diabetes, Inflammation, Methylation |
Databáze: | OpenAIRE |
Externí odkaz: |